Cargando…
ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
AT-rich interactive domain 1A (ARID1A) and AT-rich interactive domain 1B (ARID1B) are subunits of the SWI/SNF chromatin complex. ARID1A is a tumor suppressor gene that is frequently mutated (46%) in ovarian clear cell carcinomas (OCCC). Loss of ARID1B in an ARID1A-deficient background eliminates the...
Autores principales: | Sato, Emi, Nakayama, Kentaro, Razia, Sultana, Nakamura, Kohei, Ishikawa, Masako, Minamoto, Toshiko, Ishibashi, Tomoka, Yamashita, Hitomi, Iida, Kouji, Kyo, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032401/ https://www.ncbi.nlm.nih.gov/pubmed/29890703 http://dx.doi.org/10.3390/ijms19061710 |
Ejemplares similares
-
High PD-1 expression level is associated with an unfavorable prognosis in patients with cervical adenocarcinoma
por: Ishikawa, Masako, et al.
Publicado: (2020) -
Mucinous borderline ovarian tumors with BRAF(V600E) mutation may have low risk for progression to invasive carcinomas
por: Ohnishi, Kaori, et al.
Publicado: (2020) -
KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
por: Nakamura, Kohei, et al.
Publicado: (2016) -
Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients
por: Ishikawa, Masako, et al.
Publicado: (2018) -
Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas
por: KATAGIRI, HIROSHI, et al.
Publicado: (2015)